Prevalence and disease burden of HCV coinfection in HIV cohorts in the Asia pacific region: A systematic review and meta-analysis

AIDS Reviews

Volumn 18, Issue 2, 2016, Pages 69-80

  Martinello, Marianne ^a   Amin, Janaki ^a   Matthews, Gail V ^a   Dore, Gregory J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Asia; Coinfection; Epidemiology; HCV; HIV; Prevalence

Indexed keywords

COINFECTION; COMPLICATION; FAR EAST; HEPACIVIRUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; PREVALENCE; VIROLOGY;

COINFECTION; FAR EAST; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; PREVALENCE;

EID: 84969909585     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epide-miology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333-42.
2. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epide-miology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61:S45-57.
3. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2013 [13 March 2015]. Available at: http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Global_Report_2013_en_1.pdf.
4. Murray CJL, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:1005-70.
5. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335-74.
6. UNITAID. Hepatitis C medicines: Technology and market landscape 2015 2015 [13 March 2015]. Available at: http://unitaid.org/images/marketdynamics/publications/HCV_Meds_Landscape_Feb2015.pdf.
7. Hernando V, Perez-Cachafeiro S, Lewden C, et al. All-cause and liver-related mortality in HIV positive subjects compared to the general pop-ulation: differences by HCV coinfection. J Hepatol. 2012;57:743-51.
8. Crowell TA, Gebo KA, Balagopal A, Fleishman JA, Agwu AL, Berry SA. Impact of hepatitis coinfection on hospitalization rates and causes in a multicenter cohort of persons living with HIV. J Acquir Immune Defic Syndr. 2014;65:429-37.
9. Branch AD, Van Natta ML, Vachon ML, Dieterich DT, Meinert CL, Jabs DA. Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy. Clin Infect Dis. 2012;55:137-44.
10. Pineda JA, Romero-Gomez M, Diaz-Garcia F, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decom-pensated cirrhosis. Hepatology. 2005;41:779-89.
11. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-128.
12. Collaborators GMaCoD. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990– 2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117-71.
13. UNAIDS. HIV in Asia and the Pacific: UNAIDS report 2013 [13 March 2015]. Available at: http://www.unaids.org/sites/default/files/media_as-set/2013_HIV-Asia-Pacific_en_0.pdf.
14. Lim RB, Tan MT, Young B, et al. Risk factors and time-trends of cytomegalovirus (CMV), syphilis, toxoplasmosis and viral hepatitis infection and seroprevalence in human immunodeficiency virus (HIV) infected patients. Ann Acad Med Singapore. 2013;42:667-73.
15. Kirby Institute. TAHOD-LITE: Antiretroviral Treatment for Adult HIV Infection in Asia, 1998 to 2013. Kirby Institute, UNSW Australia, 2015.
16. Tian D, Li L, Liu Y, Li H, Xu X, Li J. Different HCV genotype distributions of HIV-infected individuals in Henan and Guangxi, China. PLoS One. 2012;7:e50343.
17. An MH, Han XX, Liu J, et al. [Study on the rates of infection and spon-taneous clearance on HCV among HIV-infected men who have sex with men in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2013;34:15-8.
18. Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immuno-deficiency virus infection in Central China. Arch Virol. 2013;158:1889-94.
19. Dong Y, Qiu C, Xia X, et al. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study. Arch Virol. 2015;160: 929-36.
20. Feng L, Ding X, Xu J, Ou Y, Xu S. [Study on HIV, Syphilis and HCV Prevalence and Its Assoicated Factors among Internet MSM Comparison to Non-Internet MSM in Chongqing]. J Trop Med. 2010;10:78-82.
21. He N, Chen L, Lin HJ, et al. Multiple viral coinfections among HIV/AIDS patients in China. Biosci Trends. 2011;5:1-9.
22. Liu J, Li N, Liu C, et al. [Analysis on hepatitis C virus infection and related factors among newly reported HIV infections in Henan province]. Zhonghua Liu Xing Bing Xue Za Zhi. 2014;35:935-8.
23. Maimaiti R, Zhang Y, Pan K, Wubuli M, Andersson R. Frequent coinfection with hepatitis among HIV-positive patients in Urumqi, China. J Int Assoc Provid AIDS Care. 2013;12:58-61.
24. Shang H, Zhong P, Liu J, et al. High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China. PLoS One. 2010;5:e10631.
25. Shen YZ, Wang ZY, Qi TK, et al. Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China. HIV Med. 2013;14:167-75.
26. Wang W, Ma Y, Jiang S, Yang Y, Zhang X. [Investigation on HIV and hepatitis C co-infection among men who have sex with men in Beijing]. Chinese J Pub Health. 2011;27:624-5.
27. Yan YX, Gao YQ, Sun X, et al. Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients. Epidemiol Infect. 2011;139:354-60.
28. Zhang F, Zhu H, Wu Y, et al. HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: a retrospective observational cohort study. Lancet Infect Dis. 2014;14:1065-72.
29. Zhang T, He N, Ding Y, Crabtree K, Minhas V, Wood C. Prevalence of human herpesvirus 8 and hepatitis C virus in a rural community with a high risk for blood-borne infections in central China. Clin Microbiol Infect. 2011;17:395-401.
30. Zhang T, Tully DC, Zhou S, He N. Characteristics of HCV co-infection among HIV infected individuals from an area with high risk of blood-borne infections in central China. PLoS One. 2014;9:e94219.
31. Zhao R, Peng J, Tang L, et al. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low. J Med Virol. 2013;85:1712-23.
32. Zhao YS, Su SI, Lv CX et al. Seroprevalence of hepatitis C, hepatitis B virus and syphilis in HIV-1 infected patients in Shandong, China. Int J STD AIDS. 2012;23:639-43.
33. Jain M, Chakravarti A, Verma V, Bhalla P. Seroprevalence of hepatitis viruses in patients infected with the human immunodeficiency virus. Indian J Pathol Microbiol. 2009;52:17-9.
34. Kosaraju K, Padukone S, Bairy I. Co-infection with hepatitis viruses among HIV-infected individuals at a tertiary care centre in South India. Trop Doct. 2011;41:170-1.
35. Raizada A, Dwivedi S, Bhattacharya S. Hepatitis B, hepatitis C and HIV co-infection at an antiretroviral centre in Delhi. Trop Doct. 2011;41: 154-6.
36. Saha K, Firdaus R, Santra P, et al. Recent pattern of Co-infection amongst HIV seropositive individuals in tertiary care hospital, Kolkata. Virol J. 2011;8:116.
37. Ponamgi SP, Rahamathulla S, Kumar YN, et al. Prevalence of hepatitis C virus (HCV) coinfection in HIV infected individuals in south India and characterization of HCV genotypes. Indian J Med Microbiol. 2009;27:12-6.
38. Chandra N, Joshi N, Raju YS, Kumar A, Teja VD. Hepatitis B and/or C co-infection in HIV infected patients: a study in a tertiary care centre from South India. Indian J Med Res. 2013;138:950-4.
39. Nagmoti MB, Patil CS, Jyoti MN, Mutnal MB, Mallapur MD. Prevalence of hepatitis C infection in HIV-seropositive individuals in and around Belgaum, south India. Int J STD AIDS. 2012;23:e14-5.
40. Alvarez-Uria G, Midde M, Pakam R, Naik PK. Gender differences, routes of transmission, socio-demographic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India. Infect Dis Rep. 2012;4:e19.
41. Barnawal SP, Niraula SR, Agrahari AK, Bista N, Jha N, Pokharel PK. Human immunodeficiency virus and hepatitis C virus coinfection in Ne-pal. Indian J Gastroenterol. 2014;33:141-5.
42. Poudel KC, Palmer PH, Jimba M, Mizoue T, Kobayashi J, Poudel-Tan-dukar K. Coinfection with hepatitis C virus among HIV-positive people in the Kathmandu Valley, Nepal. J Int Assoc Provid AIDS Care. 2014;13: 277-83.
43. van Griensven J, Phirum L, Choun K, Thai S, De Weggheleire A, Lynen L. Hepatitis B and C coinfection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia. PLoS One. 2014;9:e88552.
44. Zaw SK, Tun ST, Thida A, et al. Prevalence of hepatitis C and B virus among patients infected with HIV: a cross-sectional analysis of a large HIV care programme in Myanmar. Trop Doct. 2013;43:113-5.
45. Jatapai A, Nelson KE, Chuenchitra T, et al. Prevalence and risk factors for hepatitis C virus infection among young Thai men. Am J Trop Med Hyg. 2010;83:433-9.
46. Phuangchoei P, Chotiyaputta W, Chayakulkeeree M. Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients. J Med Assoc Thai. 2015;98:226-31.
47. Tsuchiya N, Pathipvanich P, Rojanawiwat A, et al. Chronic hepatitis B and C co-infection increased all-cause mortality in HAART-naive HIV patients in Northern Thailand. Epidemiol Infect. 2013;141:1840-8.
48. Ngo-Giang-Huong N, Jourdain G, Sirirungsi W, et al. Human immuno-deficiency virus-hepatitis C virus coinfection in pregnant women and perinatal transmission to infants in Thailand. Int J Infect Dis. 2010;14: e602-7.
49. Huy BV, Vernavong K, Kinh NV. HBV and HCV Coinfection among HIV/ AIDS Patients in the National Hospital of Tropical Diseases, Vietnam. AIDS Res Treat. 2014;2014:581021.
50. Anggorowati N, Yano Y, Heriyanto DS, et al. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients. J Med Virol. 2012;84:857-65.
51. Wisaksana R, Indrati AK, Fibriani A, et al. Response to first-line anti-retroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia. Addiction. 2010;105:1055-61.
52. Juniastuti, Utsumi T, Nasronudin, et al. High rate of seronegative HCV infection in HIV-positive patients. Biomed Rep. 2014;2:79-84.
53. Durier N, Ruxrungtham K, Avihingsanon A, et al. Hepatitis C virus RNA and genotype, IL28B genotype, and liver fibrosis scores in a regional cohort of HIV-HCV co-infected patients under routine HIV care in Asia. Hepatology. 2014;6(Suppl 1):941A [Abstract].
54. Lerolle N, Limsreng S, Fournier-Nicolle I, et al. High Frequency of Advanced Hepatic Disease among HIV/HCV Co-Infected Patients in Cambodia: The HEPACAM Study (ANRS 12267). J AIDS Clin Res. 2012;3.
55. Nelson PK, Mathers BM, Cowie B, et al. Global epidemiology of hepa-titis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378:571-83.
56. Goyet S, Lerolle N, Fournier-Nicolle I, et al. Risk factors for hepatitis C transmission in HIV patients, Hepacam study, ANRS 12267 Cambodia. AIDS Behav. 2014;18:495-504.
57. Chanbancherd P, Paris RM, Torugsa K, Myint KS, Sangkharomya S, Brown AE. Changes in HIV prevalence among young Thai men as defined by hepatitis C co-infection as a marker for mode of transmis-sion. AIDS. 2004;18:2339-41.
58. Matthews GV, Pham ST, Hellard M, et al. Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C. Clin Infect Dis. 2011;52:803-11.
59. Wandeler G, Gsponer T, Bregenzer A, et al. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis. 2012;55:1408-16.
60. van de Laar T, Pybus O, Bruisten S, et al. Evidence of a large, inter-national network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology. 2009;136:1609-17.
61. Chow EP, Tucker JD, Wong FY, et al. Disparities and risks of sexually transmissible infections among men who have sex with men in China: a meta-analysis and data synthesis. PLoS One. 2014;9:e89959.
62. Sun HY, Chang SY, Yang ZY, et al. Recent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factors. J Clin Microbiol. 2012;50:781-7.
63. Nishijima T, Shimbo T, Komatsu H, Hamada Y, Gatanaga H, Oka S. Incidence and risk factors for incident Hepatitis C infection among men who have sex with men with HIV-1 infection in a large Urban HIV clinic in Tokyo. J Acquir Immune Defic Syndr. 2014;65:213-7.
64. Ministry of Health Singapore. Update on the HIV/AIDS situation in Singapore. 2014.
65. Special Prevention Programme Surveillance Team. Hong Kong STD/ AIDS Update: A quarterly surveillance report. 2015.